About Us > Management
Stephen A. Tullman
Mr. Tullman has 30 years of biopharmaceutical global commercialization and drug development experience. He founded NeXeption in 2011 to start and build BioTech companies. He currently serves as the Chairman of NexEos Bio, Vice Chairman of Life Sciences PA, and is a member of the Board of Directors of Velicept Therapeutics, Inc. Previously, he was Chairman of Onspira Therapeutics, Inc. (acquired by Altavant Sciences), Chairman of Aclaris Therapeutics, Inc. (NASDAQ: ACRS), Chairman of Ralexar Therapeutics, Inc., Chairman & CEO of Ceptaris Therapeutics (acquired by Actelion), Chairman of Vicept Therapeutics (acquired by Allergan), CEO of Ception Therapeutics (acquired by Cephalon), CBO of Trigenesis (acquired by Dr. Reddy's Laboratories). Mr. Tullman is also a co-founder and board director of two IT driven companies, Zoomi, artificial intelligence for learning, and Myota, data warehouse security. Mr. Tullman started his career at SmithKline Beecham (GSK) and held positions of increasing responsibility in Finance, Sales, Marketing, and R&D. Mr. Tullman earned a BSc from Rutgers University.